Mass General Brigham has spun out AIwithCare, a company commercializing RECTIFIER, an AI tool that automates and enhances clinical trial patient screening using EHR data.
Key Details
- 1RECTIFIER, developed at Mass General Brigham, leverages Retrieval-Augmented Generation (RAG) AI to assess patient eligibility for clinical trials via EHRs, including unstructured notes and reports.
- 2In a 2024 NEJM AI study, RECTIFIER outperformed manual screening methods for a heart failure trial at lower cost.
- 3A randomized-controlled trial involving nearly 4,500 patients showed RECTIFIER doubled the enrollment rate compared to manual screening, with no differences across demographic groups.
- 4RECTIFIER is in use for over 20 clinical and research applications including oncology, neurology, pathology, and cardiology.
- 5Mass General Brigham Innovation facilitated the spinout, aiming for broader deployment across health systems via the AIwithCare platform.
- 6RECTIFIER is also being applied to population health and referral triage, showing >94% accuracy in select use cases.
Why It Matters

Source
EurekAlert
Related News

Sandia Labs Deploys AI-Augmented Imaging for Ceramic Component Inspections
Sandia National Laboratories is introducing AI-assisted optical and acoustic imaging systems to streamline and improve ceramic component inspections for nuclear deterrence.

AI and Deep Learning Reveal Menopause's Asynchronous Impact on Female Organs
An AI-powered atlas maps how menopause uniquely affects aging in individual female reproductive organs using tissue imaging and gene expression data.

AI State-Space Model Enhances Hyperspectral Image Resolution
Researchers introduce PLGMamba, an innovative AI model improving hyperspectral image super-resolution by leveraging local-global spectral feature modeling.